TruVic
TruVic Private Limited is a Sri Lankan pharmaceutical distribution and marketing company that acts as the exclusive regional partner for 10 international pharma principals across Sri Lanka, Cambodia, Maldives, and Myanmar, reaching 2,500+ outlets with 150+ field staff and operating its own branded cardio-metabolic portfolio.
- Company typePrivate
- Founded2018
- HeadquartersPannipitiya, Sri Lanka
- Headcount101–250
- GTM typeB2B
- OfferingServices
What TruVic does
TruVic Private Limited is a Sri Lankan pharmaceutical and consumer healthcare distribution and marketing company, incorporated in February 2018 and headquartered in Pannipitiya with a regional office in Dubai, UAE. The company's core business is acting as the exclusive marketing and distribution partner for international pharmaceutical principals in South and Southeast Asia, distributing generic and branded medicines across an island-wide network of more than 2,500 outlets (chemists, modern trade outlets, medical institutions, and State Pharmaceutical Corporation channels) supported by 150+ field staff in Sri Lanka, with parallel operations in Cambodia, Maldives and a nominated mandate for Myanmar. Its product portfolio spans principal-distributed respiratory, cardiovascular, diabetes, dermatological, antibiotic, and nutraceutical products from 10 supply partners across Bangladesh, India, Pakistan, Sri Lanka, and Australia, alongside a proprietary branded portfolio (BISOVIC, SITAVIC, EMPAVIC, GLIVIC, LINAVIC, ESORAL) targeting chronic disease categories.
The business model is distribution- and marketing-fee based: TruVic generates margins on product distribution and is nominated as regional marketing partner by each principal, with explicit activity in managing the medical fraternity and retail channel relationships rather than manufacturing at scale. Founder/CEO Palitha Thenuwara (37 years of pharma experience ex-Ranbaxy, Zydus Cadila, Torrent, CCL Pharmaceuticals) leads a management team that includes a Director/GM Sales & Marketing, a Director/CEO of the TruVic Consumer division, a GM of Finance/Admin/HR, and a Head of Sales & Operations. The company is privately held with no disclosed external investors, funding, or public listing, operating at 101–250 employees across at least four countries with channel-partner and field-sales-driven go-to-market motion.
TruVic firmographics
Firmographics- Name
- TruVic
- Legal name
- TruVic Private Limited
- Website
- https://truviclanka.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- TruVic Private Limited is a Sri Lankan pharmaceutical distribution and marketing company that acts as the exclusive regional partner for 10 international pharma principals across Sri Lanka, Cambodia, Maldives, and Myanmar, reaching 2,500+ outlets with 150+ field staff and operating its own branded cardio-metabolic portfolio.
- Ownership category
- akta.pro rank
TruVic industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD)
- akta.pro secondary industry
- Customs Brokerage, Trade Compliance & Import/Export for Life Sciences (HLAGAMAI)
Keywords
Where TruVic is headquartered
LocationHeadquarters
- HQ city
- Pannipitiya
- HQ country
- Sri Lanka
- HQ region
- Asia
Offices2 records
Markets served
TruVic business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Operations, Regulatory or Compliance, Others
Revenue model
- Pharmaceutical Distribution: TruVic distributes pharmaceutical and healthcare products from international principals (Bangladesh, India, Pakistan, Australia, Sri Lanka) to pharmacies, medical institutions, and retail outlets across Sri Lanka, Cambodia, Maldives, and Myanmar. Revenue is generated through margins on product distribution and marketing fees from principals.
Go-to-market motion2 records
Distribution channels6 records
Marketing channels4 records
TruVic product offering
Product offeringCore offering
TruVic is a pharmaceutical distribution and marketing company that distributes medicines and healthcare products from international principals to pharmacies, hospitals, and government health programs across Sri Lanka, Cambodia, the Maldives, and Myanmar. The company also markets its own portfolio of branded generic pharmaceutical products including BISOVIC, SITAVIC, EMPAVIC, GLIVIC, LINAVIC, and ESORAL, addressing therapeutic areas such as cardiovascular, diabetes, and gastrointestinal care.
Product overview
TruVic Private Limited is a Sri Lankan pharmaceutical and healthcare product distribution company that markets high-quality pharmaceutical and consumer healthcare products. The company operates a dual-model approach: (1) it manufactures and markets its own brand of products including BISOVIC, SITAVIC, EMPAVIC, GLIVIC, LINAVIC, and ESORAL for Respiratory, Cardiovascular, and Diabetic conditions; and (2) it serves as marketing and distribution partner for multiple international pharmaceutical suppliers including Eskayef Pharmaceuticals (Bangladesh), Biopharma (Bangladesh), Beximco Pharmaceuticals (Bangladesh), Highnoon Laboratories (Pakistan), Saffron Pharmaceuticals (Pakistan), Astron (Sri Lanka), Lina Manufacturing (Sri Lanka), Route2Health (Pakistan), Elixar Australia, and Pacific Pharmaceuticals. The portfolio spans respiratory inhalers, cardiovascular medications, diabetes treatments, antibiotics, dermatological products, nutritional supplements, and herbal remedies. Distribution operations cover Sri Lanka, Cambodia, Maldives, and Myanmar through an island-wide network of over 2,500 outlets including chemists, modern trade outlets, medical institutions, and State Pharmaceutical Corporation outlets, supported by 150+ field staff.
Differentiator
Problem solved
Functional benefit
Products and services
- BISOVIC BISOVIC is one of TruVic's proprietary branded generic pharmaceutical products marketed through its distribution network across Sri Lanka, Cambodia, the Maldives, and Myanmar.
- SITAVIC
- EMPAVIC
- GLIVIC
- LINAVIC
- ESORAL
- Pharmaceutical distribution services for international principals
Companies that use TruVic
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles1 record
TruVic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
TruVic partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and supporting.
- Eskayef Pharmaceuticals Ltd.coreEskayef Pharmaceuticals Ltd., a successor of SmithKline & French (SK&F), USA acquired by TRANSCOM in 1990. One of TruVic's principal supply partners from Bangladesh providing pharmaceutical products for distribution in Sri Lanka, Cambodia, Myanmar, and Maldives.
- Biopharma Ltd.coreBiopharma Ltd. is one of the fastest-growing business conglomerates in Bangladesh with 17 years of history, committed to serving mankind with finest quality pharmaceuticals and FMCG products. Serves as a principal supply partner for TruVic.
- Beximco Pharmaceuticals Ltd.coreBeximco Pharmaceuticals Ltd. is an emerging generic drug player committed to providing access to affordable medicines. State-of-the-art manufacturing facilities accredited by USA, Australia, EU, Canada, and Brazil regulatory authorities. Principal supply partner for TruVic.
- Astron Ltd.coreAstron Ltd. is a fully Sri Lankan-owned company incorporated in 1956, creating a milestone by setting up the first pharmaceutical manufacturing facility in Sri Lanka. Principal supply partner from Sri Lanka.
- Highnoon Laboratories Ltd.coreHighnoon Laboratories Ltd. was incorporated in March 1984 in Lahore, Pakistan, becoming a Public Limited Company in 1995 listed on all Pakistan stock exchanges. A leader in development, production, marketing and distribution of modern, high quality and affordable medicines. Principal supply partner from Pakistan.
- Saffron Pharmaceuticals Pvt Ltd.coreSaffron Pharmaceuticals Pvt Ltd. is one of the leading healthcare companies in Pakistan committed to manufacturing and marketing innovative medicines. Established in 1997 as a marketing company with remarkable reputation in the pharmaceutical industry. Principal supply partner from Pakistan.
- Lina Manufacturing Pvt. Ltd.coreLina Manufacturing Pvt. Ltd. has used its R&D acumen for over a decade to develop pharmaceutical products for both public and private sector. Committed to bringing quality medicine to all Sri Lankans. Operates the island's only metered dosage inhaler manufacturing facility. Principal supply partner from Sri Lanka.
- Pacific Pharmaceuticals Ltd.supportingPrincipal supply partner from Pakistan, providing pharmaceutical products for distribution through TruVic's network.
- Elixar Australia Pty Ltd.coreElixar Australia Pty Ltd. is an Australian company providing premium quality complementary healthcare products (nutraceuticals). Their aim is to make premium quality nutraceutical products widely accessible without premium price tags. Principal supply partner from Australia.
- Route2HealthsupportingRoute2Health is a world-class herbal remedy and dietary supplement manufacturer with thirty years of experience in pharmaceutical science associated with Highnoon Laboratories. Provides PROSPAN herbal cough syrup products.
Scale indicators4 records
Recent moves8 records
Expansion highlights4 records
TruVic competitors and assessment
Company assessmentDirect peers
- Sunshine Healthcare Lanka: Leading Sri Lankan pharmaceutical importer, marketer, and distributor covering pharmaceuticals, medical devices, and consumer health, with broad island-wide retail and institutional coverage analogous to TruVic.
- Mega Lifesciences: Thailand-headquartered pharma and consumer healthcare distribution company operating across emerging Asia and Africa; comparable in its regional emerging-markets distribution and own-brand strategy.
- CICRA Pharmaceuticals: Sri Lankan pharmaceutical marketing and distribution company supplying branded generics across therapeutic categories to pharmacies and hospitals, directly overlapping with TruVic's principal-partner distribution model.
- Ceyoka Pharma Distribution: Sri Lankan pharmaceutical distribution and marketing company focused on branded generics, directly comparable to TruVic's Sri Lankan retail and pharmacy distribution operations.
Broad incumbents
- Zuellig Pharma: One of Asia's largest pharmaceutical distribution services providers with extensive GDP-compliant warehousing and multi-country reach; represents the scaled version of what TruVic is building in smaller Asian markets.
- Hemas Holdings: Sri Lankan conglomerate with a large pharmaceutical and healthcare distribution segment; the most established local incumbent to TruVic's distribution model, though operating across multiple categories beyond pharma.
- DKSH: Swiss-listed market expansion services company with a sizable Healthcare distribution business across Asia; larger and more diversified than TruVic but operates the same principal-to-channel model in overlapping geographies.
Regional players
- Ascent Pharma Healthcare: Australia-headquartered pharma distributor with growing emerging-markets presence (including Asia); comparable in operating as an Asian regional distribution partner for international principals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
TruVic social profiles
Digital presenceTruVic financial estimates
Financial estimateRevenue estimate
Valuation estimate
TruVic leadership team
Management profileNumber of profiles
Profiles1 record
TruVic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TruVic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TruVic
What does TruVic do?
TruVic is a pharmaceutical distribution and marketing company that distributes medicines and healthcare products from international principals to pharmacies, hospitals, and government health programs across Sri Lanka, Cambodia, the Maldives, and Myanmar. The company also markets its own portfolio of branded generic pharmaceutical products including BISOVIC, SITAVIC, EMPAVIC, GLIVIC, LINAVIC, and ESORAL, addressing therapeutic areas such as cardiovascular, diabetes, and gastrointestinal care.
Is TruVic a public or private company?
TruVic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was TruVic founded?
TruVic was founded in 2018. It employs 101 to 250 people.
Where is TruVic based?
TruVic is headquartered in Pannipitiya, Sri Lanka, in the Asia region.
How does TruVic make money?
One revenue line is on record: pharmaceutical Distribution.
Who are TruVic's main competitors?
Direct peers on record are Sunshine Healthcare Lanka, Mega Lifesciences, CICRA Pharmaceuticals and Ceyoka Pharma Distribution. Broad incumbents are Zuellig Pharma, Hemas Holdings and DKSH. Ascent Pharma Healthcare is listed as a regional player.
Does TruVic have an API?
No public API is recorded for TruVic.
What industry is TruVic in?
TruVic's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is TLAIACAD, Pharmaceutical & Life Sciences Warehousing (GDP-Compliant), with a secondary code of HLAGAMAI, Customs Brokerage, Trade Compliance & Import/Export for Life Sciences. Its NAICS code is 42345 and its SIC code is 5122.